Showing 1 - 11 results of 11 for search 'A. A. Lishchinskaya', query time: 0.03s
Refine Results
-
1
Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis by O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya
Published 2021-05-01
Article -
2
-
3
-
4
Comparative evaluation of the effectiveness of monotherapy of ulcerative colitis with mesalazine MMX and combination therapy with non-prolonged mesalazines with rectal forms by O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya, A. F. Babaian, T. V. Shkurko, B. A. Nanaeva, I. A. Li
Published 2022-08-01
Article -
5
-
6
Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars by O. V. Knyazev, M. Yu. Zvyaglova, A. V. Kagramanova, I. A. Li, E. A. Sabelnikova, A. A. Lishchinskaya, D. S. Kulakov, A. I. Parfenov
Published 2021-02-01
Article -
7
Stem Cell Therapy for Perianal Crohn’s Disease by O V Knyazev, N A Fadeeva, A V Kagramanova, N I Belyakov, N V Orlova, A A Lishchinskaya, A G Konoplyannikov, A I Parfenov
Published 2018-03-01
Article -
8
-
9
-
10
-
11
Efficacy and safety of tofacitinib in moderate and severe ulcerative colitis in real clinical practice: three years of observation by O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya, I. A. Li, D. V. Podolskaya, T. V. Shkurko, B. A. Nanaeva, T. L. Aleksandrov, T. A. Baranova, I. A. Tishaeva, M. Yu. Zvyaglova, A. I. Parfenov
Published 2021-10-01
Article